These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33821385)

  • 1. Management of arrhythmias in pulmonary hypertension.
    Reddy SA; Nethercott SL; Khialani BV; Grace AA; Martin CA
    J Interv Card Electrophysiol; 2021 Nov; 62(2):219-229. PubMed ID: 33821385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
    Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the management of atrial fibrillation in patients with heart failure.
    Khand AU; Rankin AC; Kaye GC; Cleland JG
    Eur Heart J; 2000 Apr; 21(8):614-32. PubMed ID: 10731399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery?
    Barbetakis N; Vassiliadis M
    BMC Surg; 2004 Jun; 4():7. PubMed ID: 15191616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of ventricular dysrhythmia in aconite poisoning.
    Coulson JM; Caparrotta TM; Thompson JP
    Clin Toxicol (Phila); 2017 Jun; 55(5):313-321. PubMed ID: 28421842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone: an emergency medicine perspective.
    Taylor SE
    Emerg Med (Fremantle); 2002 Dec; 14(4):422-9. PubMed ID: 12534486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
    Singh BN
    Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological therapy of atrial fibrillation and atrial flutter].
    Grönefeld GC; Li YG; Hohnloser SH
    Herz; 2002 Jun; 27(4):329-44. PubMed ID: 12187863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.
    Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A
    Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.
    Opolski G; Stanisławska J; Górecki A; Swiecicka G; Torbicki A; Kraska T
    Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study.
    Balik M; Waldauf P; Maly M; Matousek V; Brozek T; Rulisek J; Porizka M; Sachl R; Otahal M; Brestovansky P; Svobodova E; Flaksa M; Stach Z; Pazout J; Duska F; Smid O; Stritesky M
    BMJ Open; 2019 Sep; 9(9):e031678. PubMed ID: 31481571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
    Singh BN
    Heart Fail Rev; 2002 Jul; 7(3):285-300. PubMed ID: 12215733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous antiarrhythmic agents.
    Pinter A; Dorian P
    Curr Opin Cardiol; 2001 Jan; 16(1):17-22. PubMed ID: 11124714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.